2012
DOI: 10.1016/j.pmr.2012.06.011
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Approach to the Diagnostic Evaluation of Hereditary and Acquired Neuromuscular Diseases

Abstract: SYNOPSIS In the context of a neuromuscular disease diagnostic evaluation, the clinician still must be able to obtain a relevant patient and family history and perform focused general, musculoskeletal, neurologic and functional physical examinations to direct further diagnostic evaluations. Laboratory studies for hereditary neuromuscular diseases include relevant molecular genetic studies. The EMG and nerve conduction studies remain an extension of the physical examination and help to guide further diagnostic s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
60
1
4

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 95 publications
(65 citation statements)
references
References 95 publications
0
60
1
4
Order By: Relevance
“…A majority of the most commonly disrupted genes in muscle disease are poorly expressed in blood and fibroblasts, suggesting that RNA-seq from these easily accessible tissues may be underpowered to detect relevant transcriptional aberrations in certain genes. For these reasons, we chose to pursue RNA-seq from primary muscletissue biopsies, which are routinely performed as part of the diagnostic evaluation of undiagnosed muscle disease patients (21, 22). …”
Section: Resultsmentioning
confidence: 99%
“…A majority of the most commonly disrupted genes in muscle disease are poorly expressed in blood and fibroblasts, suggesting that RNA-seq from these easily accessible tissues may be underpowered to detect relevant transcriptional aberrations in certain genes. For these reasons, we chose to pursue RNA-seq from primary muscletissue biopsies, which are routinely performed as part of the diagnostic evaluation of undiagnosed muscle disease patients (21, 22). …”
Section: Resultsmentioning
confidence: 99%
“…Signs of myopathy may be detected from birth through laboratory findings although the clinical sign usually occurs later between two and three years of age (Gardner-Medwin, 1980;McDonald, 2012). Creatine kinase (CK) blood levels are often utilized as diagnostic markers for DMD (Cacchiarelli, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Neuropathies. 51,52 Pathophysiology of respiratory failure in NMD Children with progressive NMD undergo a typical evolution of respiratory impairment. Weakness that involves respiratory muscles, which includes the diaphragm, chest wall, and bulbar control, can lead to the inability to take deep breaths and to clear secretions effectively from the airways.…”
Section: Myopathies; (Ii) Central Nervous System Disorders; and (Iii)mentioning
confidence: 99%